Clinical Trial Update: A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study of AMG 208 in patients with advanced solid tumors has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• AMG 208

Snippet

Sponsor: Amgen | Conditions: Cancer, Oncology | Phase 1 | Status: COMPLETED